The influence of demographics and comorbidity on persistence with anti-seizure medication

Epilepsy is among the most common neurological disorders, affecting an estimated 50 million people worldwide. [1] The National Institute for Health and Care Excellence (NICE) estimated the prevalence of active epilepsy (i.e. patients with continuing seizures or continued need for treatment) in the UK to be 500-1,000 cases per 100,000 population, and the incidence of newly diagnosed epilepsy to be 50 per 100,000 population per year. [2]

0